Medical Devices Latin America

Latin America Molecular Diagnostics Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Latin America Molecular Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Technology, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Latin America · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $1.19 Bn Placeholder estimate
Estimate 2025 $1.32 Bn 4.4% of the global market
Projected 2034 $3.35 Bn 153.7% Adds $2.03 Bn over 9 forecast years
CAGR 2025–2034 10.9% Faster than 62% of 193 Medical Devices markets here
Key players 6 +1
  • Latin America is 4.36% of the global market.
  • Among regions, the largest is North America at $16.35 Bn.
  • Fastest growing: Middle East at 11.3% a year.
  • Latin America ranks 4th of 6 by size among regions.

Market size projection

Latin America

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$2.03 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Molecular Diagnostics Market market size by year, Latin America
YearMarket sizeChange that yearSince 2025
2024 (estimate) $1.19 Bn — —
2025 (base) $1.32 Bn +$129.8 Mn —
2026 (forecast) $1.46 Bn +$143.9 Mn +10.9%
2027 (forecast) $1.62 Bn +$159.6 Mn +23%
2028 (forecast) $1.80 Bn +$177.0 Mn +36.4%
2029 (forecast) $2.00 Bn +$196.3 Mn +51.3%
2030 (forecast) $2.21 Bn +$217.7 Mn +67.7%
2031 (forecast) $2.46 Bn +$241.4 Mn +86%
2032 (forecast) $2.72 Bn +$267.7 Mn +106.3%
2033 (forecast) $3.02 Bn +$296.9 Mn +128.8%
2034 (forecast) $3.35 Bn +$329.3 Mn +153.7%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Latin America Molecular Diagnostics Market Analysis at a glance
Market size, 2025$1.32 Bn placeholder estimate
Forecast, 2034$3.35 Bn placeholder estimate
Growth (CAGR), 2025–203410.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTechnology, application and end user (see all)
Key playersRoche, Abbott Laboratories, Thermo Fisher Scientific Inc., Qiagen N.V., Hologic, Inc. and 1 more (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Latin America Molecular Diagnostics Market Analysis Executive Summary

Molecular diagnostics tests read DNA, RNA and proteins to find infections, cancer and inherited disease.

Key segments of the molecular diagnostics market include technology (PCR, Sequencing and Isothermal Amplification) and application (Infectious Disease, Oncology and Genetic Disease).

Bar chart: Latin America Molecular Diagnostics market size, 2024–2034, placeholder estimates. $1.19 Bn in 2024, $1.32 Bn in 2025 and $3.35 Bn in 2034, 10.9% CAGR.
Latin America Molecular Diagnostics market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Latin America Molecular Diagnostics Market Dynamics

Market Growth Drivers

Falling costs of testing, more demand for precision medicine and steady research spending by drug makers and labs are driving the molecular diagnostics market.

Opportunity

Automation, smaller and cheaper instruments and growth in cancer and genetic testing give the molecular diagnostics market room to grow.

Market Restraints

Costly instruments, a shortage of skilled lab staff and uneven payment for new tests hold back the molecular diagnostics market.

Competitive Landscape for Molecular Diagnostics Market in Latin America

The molecular diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Molecular Diagnostics Market in Latin America

Molecular Diagnostics in Latin America: rules and payment

In some of the countries we cover here, medical devices are regulated by ANVISA (Brazil)⁠[1], ARCSA (Ecuador)⁠[2], COFEPRIS (Mexico)⁠[3], ANMAT (Argentina)⁠[4], INVIMA (Colombia)⁠[5] and ISP (Chile)⁠[6]. How care is paid for in some of these countries: the SUS (Brazil)⁠[7]; public care and IESS (Ecuador)⁠[8]; IMSS, ISSSTE and IMSS-Bienestar (Mexico)⁠[9]; public care, obras sociales and prepaid plans (Argentina)⁠[10]; social health insurance (EPS) (Colombia)⁠[11]; and FONASA and ISAPREs (Chile)⁠[12].

[1] ANVISA. Checked 14 Nov 2026.

[2] ARCSA. Checked 14 Nov 2026.

[3] COFEPRIS. Checked 14 Nov 2026.

[4] ANMAT. Checked 19 Nov 2026.

[5] INVIMA. Checked 19 Nov 2026.

[6] Institute of Public Health of Chile (ISP). Checked 19 Nov 2026.

[7] CONITEC. Checked 14 Nov 2026.

[8] Ministry of Public Health of Ecuador. Checked 14 Nov 2026.

[9] Mexican Social Security Institute (IMSS). Checked 14 Nov 2026.

[10] Superintendence of Health Services (SSSalud). Checked 19 Nov 2026.

[11] Ministry of Health and Social Protection. Checked 19 Nov 2026.

[12] FONASA. Checked 19 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how molecular diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Latin America.

Public data, with sources

Molecular Diagnostics in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Molecular Diagnostics market in Latin America?
Placeholder estimate: about $1.32 Bn in 2025, rising to about $3.35 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Molecular Diagnostics market in Latin America growing?
Placeholder estimate: about 10.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Molecular Diagnostics market report cover?
The report splits the market by technology (PCR, Sequencing, Isothermal Amplification, Microarrays and more), application (Infectious Disease, Oncology, Genetic Disease, Blood Screening) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Molecular Diagnostics market?
Key players include Roche, Abbott Laboratories, Thermo Fisher Scientific Inc., Qiagen N.V., Hologic, Inc. and Danaher Corporation.
What is driving the Molecular Diagnostics market?
Falling costs of testing, more demand for precision medicine and steady research spending by drug makers and labs are driving the molecular diagnostics market.
Back to Catalogue

Related Medical Devices reports in Latin America

See all

Related on diagnostics and lab testing and genomics

See the topic